TwinBeech Capital’s BridgeBio Pharma BBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-321,811
| Closed | -$11.1M | – | 649 |
|
|
2025
Q1 | $11.1M | Buy |
+321,811
| New | +$11.1M | 0.2% | 135 |
|
|
2024
Q4 | – | Sell |
-77,798
| Closed | -$1.98M | – | 622 |
|
|
2024
Q3 | $1.98M | Sell |
77,798
-263,449
| -77% | -$6.71M | 0.04% | 409 |
|
|
2024
Q2 | $8.64M | Buy |
+341,247
| New | +$8.64M | 0.17% | 153 |
|
|
2023
Q4 | – | Sell |
-107,409
| Closed | -$2.83M | – | 654 |
|
|
2023
Q3 | $2.83M | Buy |
+107,409
| New | +$2.83M | 0.05% | 355 |
|
|
2023
Q1 | – | Sell |
-264,325
| Closed | -$2.01M | – | 618 |
|
|
2022
Q4 | $2.01M | Buy |
+264,325
| New | +$2.01M | 0.04% | 439 |
|
|
2022
Q1 | – | Sell |
-54,398
| Closed | -$907K | – | 501 |
|
|
2021
Q4 | $907K | Buy |
54,398
+45,442
| +507% | +$758K | 0.05% | 359 |
|
|
2021
Q3 | $420K | Buy |
+8,956
| New | +$420K | 0.03% | 453 |
|